KR
KORU Medical Systems, Inc.
KRMD · NASDAQ
$3.23 +2.87% (+$0.09)
1M +0.31%
Market Cap $147.9M
P/E Ratio -
Div. Yield -
ROE 10.63%
Bulios Fair Price
$1.99
38.4% downside
Current Price
$3.23
Undervalued Fair Value Overvalued
According to Bulios Fair Price, KRMD is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
12 /100
Expensive P/FCF 561.38x
P/S 3.28x
P/B 8.19x
Growth
65 /100
Stable Book val. growth 18.36%
Rev. growth 13.81%
FCF growth N/A
Profitability
23 /100
Weak Op. margin 3.66%
Gross margin 61.99%
FCF margin 0.58%
Quality
15 /100
Poor ROA 6.51%
ROIC 7.78%
Asset turnover 1.61x
Debt
100 /100
Low Current ratio 2.72x
Debt/Equity 0.18x
Debt/Assets N/A
Stability
47 /100
Moderate EPS volatility 65.97%
Beta 0.42x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about KRMD
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Adam Kalbermatten
Employees
73
Headquarters
Mahwah
Upcoming events
11 NOV
Earnings
Upcoming earnings report